I believe there is an effort, or at least an expressed interest, in formulating Brilacidin for application via nebulizer.
The Russian clinical trial describes IV as the dosing method for the current clinical trial.
Has B been formulated for nebulizer? Possible. But for me, I’ve read three, maybe four, different articles related to the “Russian antidote” and it just doesn’t pass the smell test. I don’t think the two trails; Brilacidin’s current PhII and the Russian “cure”, cross. I’d love to be wrong. (Wouldn’t be the first time, won’t be the last.)
The Russian clinical trial describes IV as the dosing method for the current clinical trial.
Has B been formulated for nebulizer? Possible. But for me, I’ve read three, maybe four, different articles related to the “Russian antidote” and it just doesn’t pass the smell test. I don’t think the two trails; Brilacidin’s current PhII and the Russian “cure”, cross. I’d love to be wrong. (Wouldn’t be the first time, won’t be the last.)